Report
Eric Wilmer

DSM : Comforting

>4Q22 recap: Firmenich results and 2H23 language providing comfort - DSM reported 4Q22 results that were in line with Vara css. All eyes were on any colour regarding destocking, weak vitamins pricing and inflation going into 1H23. DSM appears relatively confident on destocking as well as its ability to implement further price increases, with the China-reopening likely turning out to be a support against destocking (in animal) and (as we anticipate) vitamins price vol...
Underlying
Koninklijke DSM N.V.

Royal DSM is engaged in the creation of products and services in Life Sciences and Materials Sciences. Co.'s products and services are used globally in range of markets and applications in healthcare, pharmaceutical automotive and chemicals sectors. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. The activities of Co. are grouped into four clusters: Nutrition, Pharma, Performance Materials and Polymer Intermediates.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Eric Wilmer

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch